Keyphrases
Neoadjuvant Chemotherapy
100%
Site of Disease
100%
Response to Neoadjuvant Chemotherapy
100%
Transcriptional Changes
100%
Phenotypic Change
100%
High-grade Serous Ovarian Cancer (HGSOC)
100%
Tumor
75%
Homologous Recombination Repair
50%
Post-neoadjuvant
50%
Omentum
50%
Transcriptomics
25%
Transcriptomic Data
25%
Specific Difference
25%
Immune Response
25%
Overall Survival
25%
Phenotypic Data
25%
Histological Analysis
25%
DNA Damage
25%
Score Following
25%
Transcriptome Profiling
25%
CD8+ T
25%
Cell Infiltration
25%
Focus Formation
25%
Immuno-inflammatory Response
25%
Progression-free Survival
25%
Treatment Course
25%
Immuno-oncology
25%
RAD51 Foci
25%
Genomic Instability
25%
Immunology and Microbiology
Transcriptomics
100%
Homologous Recombination
100%
Omentum
100%
Ovary
100%
Recombination Repair
100%
Cytotoxic T-Cell
50%
Immune Response
50%
Overall Survival
50%
Intravenous Immunoglobulin
50%
Gene Expression Profiling
50%
DNA Damage
50%
Cell Infiltration
50%
Progression Free Survival
50%
Genomic Instability
50%
Biochemistry, Genetics and Molecular Biology
Transcriptomics
100%
Homologous Recombination
100%
Recombination Repair
100%
T Cell
50%
Immune Response
50%
Overall Survival
50%
Gene Expression Profiling
50%
Intravenous Immunoglobulin
50%
Genome Instability
50%
RAD51
50%
CD8
50%
Progression Free Survival
50%
DNA Damage
50%
Cell Infiltration
50%
Medicine and Dentistry
Disease
100%
Neoadjuvant Chemotherapy
100%
Ovarian Cancer
100%
Neoplasm
50%
Transcriptomics
33%
Recombination Repair
33%
Homologous Recombination
33%
Omentum
33%
Oncology
16%
Cytotoxic T-Cell
16%
Gene Expression Profiling
16%
Immunoglobulin
16%
Immune Response
16%
Overall Survival
16%
DNA Damage
16%
Genomic Instability
16%
Cellular Infiltration
16%
Progression Free Survival
16%